{"id":"W1971439170","doi":"10.1182/blood-2007-12-128918","title":"Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission","year":2008,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; Takeda Oncology; Astellas Pharma; CellGenix; American Society for Blood and Marrow Transplantation; Kiadis Pharma; Therakos; WellPoint; Teva Pharmaceutical Industries; HistoGenetics; Medical College of Wisconsin; StemCyte; Enzon Pharmaceuticals; U.S. Navy; Osiris Therapeutics; Celgene; American International Group; Pfizer; Baxter International; GlaxoSmithKline; U.S. Department of Health and Human Services; Astellas Pharma US; Health Resources and Services Administration; Viropharma; Amgen; Blue Cross and Blue Shield Association; Cerus Corporation; Bristol-Myers Squibb; Bayer HealthCare; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Gastroenterology; Transplantation; White blood cell; Leukemia; Acute lymphocytic leukemia; Surgery; Acute leukemia; Lymphoblastic Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003892501,0.0001600952,0.0003895357,0.0003605388,0.0003992844,0.0005214834,0.0002119781,0.0003901655,0.0008016385],"category_scores_gemma":[0.001942316,0.000146163,0.0002126176,0.0004590131,0.0002097467,0.0003386235,0.0004087854,0.0003587481,0.0002143841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000332198,"about_ca_system_score_gemma":0.0002414484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009246657,"about_ca_topic_score_gemma":0.001431644,"domain_scores_codex":[0.9996772,0.00007359609,0.00003121989,0.00004360693,0.00007188725,0.0001025462],"domain_scores_gemma":[0.9986236,0.0002157457,0.0007208757,0.00005455279,0.00005059484,0.000334748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003527678,0.00005432013,0.9862803,0.00002445623,0.00003943166,0.002854486,0.0001156268,0.00009186937,0.0003838265,0.00003777617,0.0002687513,0.009496468],"study_design_scores_gemma":[0.0000971518,0.0009732219,0.9621375,0.0000375438,0.00007198519,0.03365165,0.0002710798,0.0003613936,0.0004951792,0.000104646,0.001791604,0.00000721552],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974675,0.001810502,0.00007317851,0.00005900574,0.0000109982,0.000007823744,0.0001268827,0.000004496741,0.0004397051],"genre_scores_gemma":[0.9986145,0.0006730662,0.00006170836,0.00006627812,0.00002551787,0.000006992502,0.0004170517,0.000002095759,0.0001326957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009246657,"threshold_uncertainty_score":0.002681792,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01679573464968815,"score_gpt":0.243223031356176,"score_spread":0.2264272967064879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}